News & Updates

First-line TB treatment: Faropenem rivals ethambutol in efficacy, with fewer side effects

31 May 2023 by

Faropenem, when used in combination with the other standard treatment drugs for the first-line treatment of tuberculosis (TB) infection, appears to be noninferior to ethambutol, with faropenem having the added benefit of lower frequency of adverse events (AEs), according to the results of an open-label study in China.

First-line TB treatment: Faropenem rivals ethambutol in efficacy, with fewer side effects

31 May 2023

Children attending childcare more prone to respiratory virus infections

31 May 2023

Children who attend childcare are at greater risk of adenovirus and human metapneumovirus infection, and they are also often exposed to other respiratory viruses in such environments, reveals a study.

Children attending childcare more prone to respiratory virus infections

31 May 2023

Vaccination protects the young against COVID-19

31 May 2023 by

COVID-19 remains a global health concern, and children and adolescents are equally affected. In fact, COVID-19 hospitalization rates in children increased during the Omicron era. [MMWR 2022;71:271-278] In children aged 5–11 years who were hospitalized during the predominance of Omicron, nearly 90 percent were unvaccinated. [MMWR 2022;71:574-581]

Vaccination protects the young against COVID-19

31 May 2023

Cidofovir tied to quicker lesion clearance in patients with monkeypox

30 May 2023

Treatment with topical cidofovir leads to faster clearance of skin lesions in patients with monkeypox but mild systemic involvement, according to a study. Time to resolution reduction can shorten isolation time and enhance the cosmetic impact in areas such as the face.

Cidofovir tied to quicker lesion clearance in patients with monkeypox

30 May 2023

HPV infection among pregnant women common, but vertical transmission infrequent

29 May 2023

Vaginal human papillomavirus (HPV) is frequently detected among pregnant women, but perinatal transmission does not appear to occur as often, according to data from the HERITAGE* study.

HPV infection among pregnant women common, but vertical transmission infrequent

29 May 2023

Can azithromycin shorten shock resolution in ICU patients?

29 May 2023

Empiric azithromycin appears to have no substantial impact on shock duration, mechanical ventilation duration, intensive care unit (ICU) length of stay (LOS), hospital LOS, or in-hospital mortality in septic shock patients admitted to the ICU, according to a study.

Can azithromycin shorten shock resolution in ICU patients?

29 May 2023

COVID-19 vaccine boosters effective against Omicron in people with substance use disorder

29 May 2023 by

COVID-19 vaccine boosters provide protection against Omicron infection and related hospitalization among people with substance use disorder, researchers from the University of Hong Kong have reported.

COVID-19 vaccine boosters effective against Omicron in people with substance use disorder

29 May 2023

Maternal influenza vaccination reduces ILI risk in infants

27 May 2023 by

Administration of maternal influenza vaccine during the first- or second-trimester of pregnancy reduces the risk of influenza-like illness (ILI) in the offspring, according to a study presented at ESPID 2023.